News

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, announced its Albuquerque, New Mexico, facility has been approved for inclusion in the Biomedical Advanced Research and Development Authority (BARDA) contract development...

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced the publication of preclinical data demonstrating the induction of robust antibody and T cell responses of its COVID-19 vaccine...

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the registration of the Russian Sputnik V vaccine against coronavirus by the National Agency of Pharmaceutical Products of People's Democratic Republic of Algeria. The vaccine was registered under the...

AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager generation, announced licensing of a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Kuehne+Nagel, a world-leading logistics company, announced that they have agreed an international supply chain arrangement to provide distribution and storage of the Covid-19 Vaccine Moderna. This...

Dr Reddy’s Laboratories (DRL) on Monday announced the start of its phase 3 clinical trial of Russia's Sputnik V Covid-19 vaccine after receiving clearance from the independent Data and Safety Monitoring Board (DSMB). DSMB’s clearance is based on the safety...

Bharat Biotech inked a purchase agreement with the Government of India on January 11 to provide 55 lakh doses of COVID-19 vaccine Covaxin at Rs 295 per dose. The Indian pharma firm will be providing its coronavirus vaccine directly to...